GENE ONLINE|News &
Opinion
Blog

2025-11-26|

Staphylococcus aureus Induces Pyroptosis in Keratinocytes Through Gasdermin A Activation

by GOAI
Share To

Researchers have identified a new mechanism by which the bacterium *Staphylococcus aureus* damages human keratinocytes, the primary cell type in the epidermis. The study reveals that the pathogen triggers pyroptosis, a form of programmed cell death, through activation of Gasdermin A in keratinocytes. This discovery provides insight into how *S. aureus* interacts with skin cells during infections and may contribute to understanding its role in inflammatory skin conditions.

The research team employed molecular analyses and advanced imaging techniques to investigate the interaction between *S. aureus* and keratinocytes. Their findings show that Gasdermin A plays a critical role in mediating pyroptosis, leading to cellular damage when exposed to this bacterium. Pyroptosis is characterized by cell swelling, membrane rupture, and release of inflammatory molecules, which can exacerbate tissue damage during infection. The study highlights the importance of Gasdermin A as a key factor in this process and sheds light on potential pathways involved in skin inflammation caused by *S. aureus*.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top